Nakao S, Moriya Y, Furuyama S, Niederman R, Sugiya H
In the outcome of changes in the BMI, moderate credibility of ICEMAN result shows that L-carnitine supplementation has no difference in changes in adults (MD: 0.1, 95%CI: 0.07 to 0.31) but has significant changes (reduced) in the younger ones (MD: 0.2, 95%CI: 0.30 to 0.10)
Nausea, vomiting, and diarrhea may decrease over time, but treatment changes can bring symptoms back
The mean (SD) number of medications prescribed per patient was 1.5 (1.4), with a median of 1 and a range of 0 to 6
We conduct an initial health assessment to determine if GLP-1 medication therapy is the right approach for you
Cardiovascular safety and benefits of GLP-1 receptor agonists